Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Amphastar Pharma (AMPH)

Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,937,008
  • Shares Outstanding, K 48,902
  • Annual Sales, $ 644,400 K
  • Annual Income, $ 137,550 K
  • 60-Month Beta 0.79
  • Price/Sales 3.02
  • Price/Cash Flow 9.11
  • Price/Book 2.89
Trade AMPH with:

Options Overview Details

View History
  • Implied Volatility 46.39% ( -6.41%)
  • Historical Volatility 27.38%
  • IV Percentile 33%
  • IV Rank 43.77%
  • IV High 79.07% on 02/13/24
  • IV Low 20.96% on 07/11/24
  • Put/Call Vol Ratio 0.19
  • Today's Volume 25
  • Volume Avg (30-Day) 39
  • Put/Call OI Ratio 0.52
  • Today's Open Interest 1,003
  • Open Int (30-Day) 988

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.75
  • Number of Estimates 4
  • High Estimate 0.86
  • Low Estimate 0.68
  • Prior Year 0.58
  • Growth Rate Est. (year over year) +29.31%

Price Performance

See More
Period Period Low Period High Performance
1-Month
36.56 +8.34%
on 07/09/24
41.53 -4.62%
on 06/24/24
-0.44 (-1.10%)
since 06/18/24
3-Month
36.56 +8.34%
on 07/09/24
46.62 -15.03%
on 05/09/24
-0.40 (-1.00%)
since 04/19/24
52-Week
36.56 +8.34%
on 07/09/24
67.66 -41.46%
on 08/09/23
-22.72 (-36.45%)
since 07/19/23

Most Recent Stories

More News
Amphastar: Q1 Earnings Snapshot

Amphastar: Q1 Earnings Snapshot

AMPH : 39.61 (-0.35%)
Amphastar: Q4 Earnings Snapshot

Amphastar: Q4 Earnings Snapshot

AMPH : 39.61 (-0.35%)
Amphastar: Q3 Earnings Snapshot

Amphastar: Q3 Earnings Snapshot

AMPH : 39.61 (-0.35%)
Betting Big On Biotech: Six Undervalued Biotech Stocks To Keep On Your Radar

Following a tumultuous performance year, the biotechnology sector is steadily regaining traction once again, with investors starting to reveal a somewhat bullish sentiment despite having to endure macroeconomic...

HALO : 54.04 (-0.48%)
KNSA : 21.23 (+0.33%)
ACAD : 17.75 (-1.39%)
HRMY : 32.04 (-1.90%)
AMPH : 39.61 (-0.35%)
INCY : 65.87 (+0.76%)
AGEN : 5.99 (-17.95%)
NVS : 106.13 (-1.02%)
PFE : 29.97 (+0.88%)
SGEN : 228.74 (-0.07%)
MRK : 125.77 (+1.22%)
RXDX : 199.92 (+0.09%)
Amphastar: Q2 Earnings Snapshot

Amphastar: Q2 Earnings Snapshot

AMPH : 39.61 (-0.35%)
Promising Small Biotech Amphastar Sees Actionable Pullback

Small-cap Amphastar Pharmaceuticals is pulling back from recent highs in an orderly fashion, potentially offering a new entry point after beating Q1 views.

AMPH : 39.61 (-0.35%)
LLY : 857.47 (+1.01%)
Amphastar: Q1 Earnings Snapshot

Amphastar: Q1 Earnings Snapshot

AMPH : 39.61 (-0.35%)
Lilly to Divest BAQSIMI to Amphastar

/PRNewswire/ -- In an effort to continue expanding the availability of BAQSIMI® to patients, Eli Lilly and Company (NYSE: LLY) and Amphastar Pharmaceuticals,...

LLY : 857.47 (+1.01%)
AMPH : 39.61 (-0.35%)
Why Shares of Amphastar Pharmaceuticals Rose Today

The company reported a record revenue year and increased EPS.

AMPH : 39.61 (-0.35%)
Amphastar: Q4 Earnings Snapshot

Amphastar: Q4 Earnings Snapshot

AMPH : 39.61 (-0.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and...

See More

Key Turning Points

3rd Resistance Point 40.93
2nd Resistance Point 40.65
1st Resistance Point 40.13
Last Price 39.61
1st Support Level 39.33
2nd Support Level 39.05
3rd Support Level 38.53

See More

52-Week High 67.66
Fibonacci 61.8% 55.78
Fibonacci 50% 52.11
Fibonacci 38.2% 48.44
Last Price 39.61
52-Week Low 36.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar